New Delhi, Oct 31: Aurobindo Pharma has posted a net profit of Rs 32.15 crore for the quarter ended September 30, 2003 as compared to Rs 20.52 crore for the quarter ended September 30, 2002. Total income has increased from Rs 308.32 crore in the SQ-02 to Rs 353.78 crore in the quarter ended September 30, 2003.
The company is approaching the shareholders on November 05, 2003 for the approval of proposed preferential equity placement. The proceeds of this placement will be utilised to repay debts and thereby reduce the interest cost and offer leverage for growth. Bureau Report